"Misinformation and lies": FDA vaccine official Peter Marks slams RFK Jr. as he resigns

Salon - Mar 29th, 2025
Open on Salon

Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, has resigned due to irreconcilable differences with Robert F. Kennedy Jr., head of the U.S. Department of Health and Human Services. Marks, who played a key role in the rollout of COVID-19 vaccines under Trump's first term, cited Kennedy's promotion of anti-vaccine theories and misinformation as reasons for his departure. Kennedy, known for his controversial views on vaccines, offered Marks the choice to resign or be fired. The resignation comes amid a broader plan by HHS to lay off 10,000 employees and close community health centers and addiction services.

The implications of Marks' resignation are significant, as it underscores the ongoing tension and challenges within U.S. health policy regarding vaccine misinformation. Kennedy's leadership and his appointment of vaccine skeptic David Geier to examine the debunked link between vaccines and autism have raised concerns among health professionals. Dr. Paul Offit, a vaccine expert, expressed concern over the potential impact on children's health, emphasizing the risk of allowing misinformation to influence health policy. This development highlights the critical debate over scientific integrity versus political influence in public health administration.

Story submitted by Fairstory

RATING

6.8
Fair Story
Consider it well-founded

The article provides a timely and largely accurate account of Dr. Peter Marks' resignation from the FDA and its implications for public health policy. It effectively highlights the controversy surrounding Robert F. Kennedy Jr.'s views on vaccines, contributing to important discussions about misinformation and government accountability. While the article benefits from credible sources and expert opinions, it could improve in balance by presenting a wider range of perspectives and enhancing transparency in sourcing. The story's clarity and readability are generally strong, though additional context would aid comprehension for a broader audience. Overall, the article successfully engages with a topic of significant public interest and potential impact, despite some areas for improvement in source quality and balance.

RATING DETAILS

8
Accuracy

The story is largely accurate, with most claims being verifiable against credible sources. Dr. Peter Marks' resignation from the FDA due to disagreements over vaccine policy under Robert F. Kennedy Jr. is substantiated by multiple reports. Marks' criticism of Kennedy's stance on vaccines aligns with his resignation letter, which is cited in the article. However, the claim about Marks being forced to choose between resignation or termination is reported but lacks direct confirmation from official statements. Additionally, the article mentions a significant layoff plan at HHS, which is corroborated by other reports, although specific figures may vary. Overall, the story presents a factual account but would benefit from more direct sourcing for certain claims.

6
Balance

The article predominantly presents the perspective of Dr. Peter Marks and his criticism of Robert F. Kennedy Jr.'s policies. While it includes a response from an HHS spokesman defending Kennedy's stance, the overall narrative leans towards highlighting the negative implications of Kennedy's views on vaccination. There is a lack of detailed exploration of Kennedy's rationale or potential positive aspects of his policies. The inclusion of quotes from Dr. Paul Offit adds some balance by providing expert opinion on the potential impact of Marks' resignation. However, a more comprehensive exploration of differing viewpoints would enhance the article's balance.

7
Clarity

The article is generally clear and well-structured, with a logical flow that guides the reader through the main events and implications of Dr. Marks' resignation. The use of direct quotes and specific examples helps clarify the key points. However, the language occasionally assumes a level of prior knowledge about the individuals and events involved, which might hinder comprehension for readers unfamiliar with the context. Simplifying some of the terminology and providing additional background information would enhance clarity for a broader audience.

7
Source quality

The article references credible sources such as The New York Times, CNN, and The Associated Press, which lend authority to the reported claims. The use of direct quotes from Dr. Marks and Dr. Offit further supports the story's credibility. However, the lack of direct attribution for some claims, such as the specifics of the HHS layoff plan, slightly diminishes the overall reliability. The story would benefit from a broader range of sources, including direct statements from Kennedy or additional independent experts, to strengthen the source quality.

6
Transparency

The article provides some context for Dr. Marks' resignation and the broader implications of Kennedy's policies. However, it lacks detailed explanations of how specific claims were verified or the methodology behind the reported figures, such as the number of HHS layoffs. There is limited disclosure of potential conflicts of interest or biases that might affect the reporting. Greater transparency in terms of sourcing and the basis for certain claims would improve the article's clarity and trustworthiness.

Sources

  1. https://www.biopharmadive.com/news/peter-marks-resign-fda-kennedy-vaccines/743922/
  2. https://www.inkl.com/news/top-vaccine-official-resigns-from-fda-criticizes-rfk-jr-for-promoting-misinformation-lies